Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Boehringer Ingelheim
National Cancer Institute (NCI)
Providence Health & Services
USWM, LLC (dba US WorldMeds)
Pfizer
Conjupro Biotherapeutics, Inc.
Pfizer
University of Chicago
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
EpiBiologics
Gustave Roussy, Cancer Campus, Grand Paris
Pfizer
Dragonfly Therapeutics
Vanderbilt-Ingram Cancer Center
University of Chicago
Aktis Oncology, Inc.
Institute of Oncology Ljubljana
ViroMissile, Inc.
AstraZeneca
Tizona Therapeutics, Inc
ALX Oncology Inc.
Dana-Farber Cancer Institute
IDEAYA Biosciences
University of Wisconsin, Madison
Adaptimmune
Boehringer Ingelheim
Immunolight, LLC
UNC Lineberger Comprehensive Cancer Center
SN BioScience
Cue Biopharma
Oscotec Inc.
VLP Therapeutics
Boehringer Ingelheim
Instituto Nacional de Cancer, Brazil
Novartis
West China Hospital
M.D. Anderson Cancer Center
Stanford University
University of Chicago
National Institutes of Health Clinical Center (CC)
TScan Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Actym Therapeutics, Inc.
Case Comprehensive Cancer Center
Sanford Health
EMD Serono
Sichuan Baili Pharmaceutical Co., Ltd.
MeiraGTx UK II Ltd